최소 단어 이상 선택하여야 합니다.
최대 10 단어까지만 선택 가능합니다.
다음과 같은 기능을 한번의 로그인으로 사용 할 수 있습니다.
NTIS 바로가기Journal of hypertension, v.21 no.12, 2003년, pp.2251 - 2257
Pringle, Edward (Royal Sussex County Hospital, Brighton, UK, Hypertension and Cardiovascular Rehabilitation Unit, University of Leuven, Belgium, Department of Medicine, AZ Maastricht, The Netherlands, Tikkurilan sosiaali-ja Terveyskeskus, Vantaa, Finland, St. Anne Hospital, Sofia, Bulgaria, Istituto Auxologico Italiano, Milan, Italy, Beaumont Hospital, Dublin, Ireland, Department of Epidemiology and Health promotion, Helsinki, Finland, Royal Infirmary, Aberdeen and Faculty of Medicine, Imperial College, Hammersmith Hospital, London, UK.) , Phillips, Charles , Thijs, Lutgarde , Davidson, Christopher , Staessen, Jan A. , de Leeuw, Peter W. , Jaaskivi, Matti , Nachev, Choudomir , Parati, Gianfranco , O'Brien, Eoin T. , Tuomilehto, Jaakko , Webster, John , Bulpitt, Christopher J. , Fagard, Robert H.
SUMMARY: OBJECTIVE To investigate whether baseline systolic blood pressure variability was a risk factor for stroke, cardiovascular mortality or cardiac events during the Syst-Eur trial.DESIGN The Syst-Eur study was a randomized, double-blind, placebo-controlled trial, powered to detect differences in stroke rate between participants on active antihypertensive treatment and placebo. Systolic blood pressure variability measurements were made on 744 participants at the start of the trial. Systolic blood pressure variability was calculated over three time frames: 24 h, daytime and night-time. The placebo and active treatment subgroups were analysed separately using an intention-to-treat principle, adjusting for confounding factors using a multiple Cox regression model.PARTICIPANTS An elderly hypertensive European population.MAIN OUTCOME MEASURES Stroke, cardiac events (fatal and non-fatal heart failure, fatal and non-fatal myocardial infarction and sudden death) and cardiovascular mortality (death attributed to stroke, heart failure, myocardial infarction, sudden death, pulmonary embolus, peripheral vascular disease and aortic dissection).RESULTS The risk of stroke increased by 80% (95% confidence interval: 17-176%) for every 5 mmHg increase in night-time systolic blood pressure variability in the placebo group. Risk of cardiovascular mortality and cardiac events was not significantly altered. Daytime variability readings did not predict outcome. Antihypertensive treatment did not affect systolic blood pressure variability over the median 4.4-year follow-up.CONCLUSION In the placebo group, but not the active treatment group, increased night-time systolic blood pressure variability on admission to the Syst-Eur trial was an independent risk factor for stroke during the trial.
Kannel JAMA 1981 10.1001/jama.1981.03310370017013 245 1225
Liu J Hypertens 1998 10.1097/00004872-199816120-00016 16 1823
JAMA 1991 10.1001/jama.1991.03460240051027 265 3255
Staessen Lancet 1997 10.1016/S0140-6736(97)05381-6 350 757
Staessen Hypertension 1999 10.1161/01.HYP.33.6.1476 33 1476
Parati J Hypertens 1987 10.1097/00004872-198702000-00013 5 93
Frattola J Hypertens 1993 10.1097/00004872-199310000-00019 11 1133
Emelianov Blood Press Monit 1998 3 173
Staessen JAMA 1999 10.1001/jama.282.6.539 282 539
Perloff JAMA 1983 10.1001/jama.1983.03330440030027 249 2792
Perloff J Hypertens 1989 7 s3
Verdecchia Hypertension 1997 10.1161/01.HYP.29.6.1218 29 1218
Amery Aging Clin Exp Res 1991 10.1007/BF03324024 3 287
Staessen Aging Clin Exp Res 1992 10.1007/BF03324072 4 85
Staessen Arch Intern Med 1998 10.1001/archinte.158.15.1681 158 1681
Kikuya Hypertension 2000 10.1161/01.HYP.36.5.901 36 901
Pickering J Hypertens 1994 10.1097/00004872-199412001-00007 12 S29
Leary Am J Hypertens 2000 10.1016/S0895-7061(00)01186-9 13 1067
Goldstein Stroke 1998 10.1161/01.STR.29.4.765 29 765
Kukla Arch Neurol 1998 10.1001/archneur.55.5.683 55 683
Imai Am J Hypertens 1997 10.1016/S0895-7061(97)00277-X 10 1281
Schwartz Am J Hypertens 2000 10.1016/S0895-7061(00)01198-5 13 1203
Mancia Blood Press 1995 10.3109/08037059509077587 4 148
Mancia J Cardiovasc Pharmacol 2000 10.1097/00005344-200000004-00003 35 S15
Parati Am J Physiol 1995 268 H1606
*원문 PDF 파일 및 링크정보가 존재하지 않을 경우 KISTI DDS 시스템에서 제공하는 원문복사서비스를 사용할 수 있습니다.
※ AI-Helper는 부적절한 답변을 할 수 있습니다.